Search
  • mlincoln214

This Missed Opportunity of a Bill

Bill H.R. 4228 also known as the Rare disease Advancement, Research and Education

(RARE) Act was proposed by André Carson, a democratic representative for Indiana’s seventh congressional district on September 6, 2019. The Rare Act intended to focus on awareness, data, research, and policies regarding identifying and finding cures for rare diseases.


Awareness: Through the bill, health professionals would increase their awareness of rare

diseases and conditions through the Agency for Healthcare Research and Quality (AHRQ).


Data: Support the Centers of Disease Control and Prevention (CDC) in creating a rare disease surveillance system to help track the epidemiology of up to four rare diseases while also expanding the infrastructure of the CDC.


Research: Increase research by expanding the Rare Diseases Clinical Research Network

(RDCRN) at the National Institute of Health (NIH). Additionally, expand the capabilities of the

NIH and CDC by improving treatments, research, and diagnostics through new and existing

programs.


Policies: The bill would require an update to the 2010 report on rare diseases made by the

National Academies of Sciences, Engineering, and Medicine.


Despite the good intentions of this bill, it was short lived in the 116th congress. With only

76 cosponsors and advocacy from 139 patient advocacy groups, this bill did not receive enough votes from congress to be made into a bill. 1 in 10 Americans live with one or more of the 7000 known rare diseases, yet even with such a high probability, passing a bill that would help this marginalized demographic is not politically expedient.


This was a missed opportunity for congress to help increase the amount of knowledge we

have on rare diseases while also improving treatment and care. It is unclear when another bill targeted for rare diseases will be introduced, but it is clear that we cannot lose another

opportunity.


How can constituents be more involved and vocal about the kind of legislation they are

interested in being passed? Or how can this bill be improved for the future if there is another

chance for reintroduction? Let us know what you think at info@pathwaystotrust.org!



10 views0 comments

Recent Posts

See All

It was a full circle moment, the kind that somehow makes you feel a little bit vindicated. As if the cosmos is admitting that all of the struggles that you and your family have endured is seen and per

The mission of Pathways To Trust is to help create allyships in the rare disease community. We facilitate relationship building between patients, patient advocates, healthcare providers, health system

Sufficient sleep is vital for everyone’s health, but many people struggle to get enough. Many rare disease patients live with chronic, debilitating pain which can make it nearly impossible to fall asl